Li, J., Shih, L. K., Markwell, S. M., Olson, C. L., Sullivan, D. P., Arvanitis, C., Ross, J. L., Lam, N. G., Nuszen, H., Hambardzumyan, D., Becher, O. J., & Brat, D. J. (2025). A clinically relevant model and method to study necrosis as a driving force in glioma restructuring and progression. Proceedings of the National Academy of Sciences of the United States of America, 122(7), e2416024122.
McManus, D. T., Valanparambil, R. M., Medina, C. B., Scharer, C. D., McGuire, D. J., Sobierajska, E., Hu, Y., Chang, D. Y., Wieland, A., Lee, J., Nasti, T. H., Hashimoto, M., Ross, J. L., Prokhnevska, N., Cardenas, M. A., Gill, A. L., Clark, E. C., Abadie, K., Kumar, A. J., Kaye, J., … Ahmed, R. (2025). An early precursor CD8+ T cell that adapts to acute or chronic viral infection. Nature, 640(8059), 772–781.
+Ross, J. L., +Puigdelloses-Vallcorba, M., +Piñero, G., +Soni, N., Thomason, W., DeSisto, J., Angione, A., Tsankova, N. M., Castro, M. G., Schniederjan, M., Wadhwani, N. R., Raju, G. P., Morgenstern, P., Becher, O. J., Green, A. L., Tsankov, A. M., & Hambardzumyan, D. (2024). Microglia and monocyte-derived macrophages drive progression of pediatric high-grade gliomas and are transcriptionally shaped by histone mutations. Immunity, 57(11), 2669–2687.e6. +equal contribution of authors.
Chen, Z., Giotti, B., Kaluzova, M., Vallcorba, M. P., Rawat, K., Price, G., Herting, C. J., Pinero, G., Cristea, S., Ross, J. L., Ackley, J., Maximov, V., Szulzewsky, F., Thomason, W., Marquez-Ropero, M., Angione, A., Nichols, N., Tsankova, N. M., Michor, F., Shayakhmetov, D. M., … Hambardzumyan, D. (2023). A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression. The Journal of clinical investigation, 133(22), e163802.
McSwain, L. F., Pillsbury, C. E., Haji-Seyed-Javadi, R., Rath, S. K., Chen, V., Huang, T., Shahab, S. W., Kunhiraman, H., Ross, J., Price, G. A., Dey, A., Hambardzumyan, D., MacDonald, T., Yu, D. S., Porter, C. C., & Kenney, A. M. (2023). YB1 modulates the DNA damage response in medulloblastoma. Scientific reports, 13(1), 8087.
Chen, Z., Soni, N., Pinero, G., Giotti, B., Eddins, D. J., Lindblad, K. E., Ross, J. L., Puigdelloses Vallcorba, M., Joshi, T., Angione, A., Thomason, W., Keane, A., Tsankova, N. M., Gutmann, D. H., Lira, S. A., Lujambio, A., Ghosn, E. E. B., Tsankov, A. M., & Hambardzumyan, D. (2023). Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma. Nature communications, 14(1), 1839.
Hashimoto, M., Araki, K., Cardenas, M. A., Li, P., Jadhav, R. R., Kissick, H. T., Hudson, W. H., McGuire, D. J., Obeng, R. C., Wieland, A., Lee, J., McManus, D. T., Ross, J. L., Im, S. J., Lee, J., Lin, J. X., Hu, B., West, E. E., Scharer, C. D., Freeman, G. J., … Ahmed, R. (2022). PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program. Nature, 610(7930), 173–181.
Morgan, M. B., Ross, J., Ellwanger, J., Phrommala, R. M., Youngblood, H., Qualley, D., & Williams, J. (2022). Sea Anemones Responding to Sex Hormones, Oxybenzone, and Benzyl Butyl Phthalate: Transcriptional Profiling and in Silico Modelling Provide Clues to Decipher Endocrine Disruption in Cnidarians. Frontiers in genetics, 12, 793306.
Chen, Z., Herting, C. J., Ross, J. L., Gabanic, B., Puigdelloses Vallcorba, M., Szulzewsky, F., Wojciechowicz, M. L., Cimino, P. J., Ezhilarasan, R., Sulman, E. P., Ying, M., Ma'ayan, A., Read, R. D., & Hambardzumyan, D. (2020). Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade. Glia, 68(10), 2148–2166.
Kaffes, I., Szulzewsky, F., Chen, Z., Herting, C. J., Gabanic, B., Velázquez Vega, J. E., Shelton, J., Switchenko, J. M., Ross, J. L., McSwain, L. F., Huse, J. T., Westermark, B., Nelander, S., Forsberg-Nilsson, K., Uhrbom, L., Maturi, N. P., Cimino, P. J., Holland, E. C., Kettenmann, H., Brennan, C. W., … Hambardzumyan, D. (2019). Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors. Oncoimmunology, 8(11), e1655360.
Núñez FJ, Mendez FM, Kadiyala P, Alghamri MS, Savelieff MG, Garcia-Fabiani MB, Haase S, Koschmann C, Calinescu AA, Kamran N, Saxena M, Patel R, Carney S, Guo MZ, Edwards M, Ljungman M, Qin T, Sartor MA, Tagett R, Venneti S, Brosnan-Cashman J, Meeker A, Gorbunova V, Zhao L, Kremer DM, Zhang L, Lyssiotis CA, Jones L, Herting CJ, Ross JL, Hambardzumyan D, Hervey-Jumper S, Figueroa ME, Lowenstein PR, Castro MG. (2019). IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response. Science translational medicine, 11(479), eaaq1427.
Ross, J. L., Cooper, L. A. D., Kong, J., Gutman, D., Williams, M., Tucker-Burden, C., McCrary, M. R., Bouras, A., Kaluzova, M., Dunn, W. D., Jr, Duong, D., Hadjipanayis, C. G., & Brat, D. J. (2017). 5-Aminolevulinic Acid Guided Sampling of Glioblastoma Microenvironments Identifies Pro-Survival Signaling at Infiltrative Margins. Scientific reports, 7(1), 15593.
Selagea, L., Mishra, A., Anand, M., Ross, J., Tucker-Burden, C., Kong, J., & Brat, D. J. (2016). EGFR and C/EBP-β oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-β isoform. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 30(12), 4098–4108.